Literature DB >> 9916707

Orientation of the Ig domains of CD8 alpha beta relative to MHC class I.

L Devine1, J Sun, M R Barr, P B Kavathas.   

Abstract

The cell surface glycoprotein CD8 functions as a coreceptor with the TCR for interaction with MHC class I. The cocrystal structure of the CD8 alpha alpha-MHC complex showed that one CD8 Ig domain provided the majority of the contact with MHC class I and that residue R4 of that domain contacted the alpha2 domain of MHC class I. We previously showed by mutational analysis that this residue was critical for binding to MHC class I. To determine which of the Ig domains for the CD8 alpha beta heterodimer would make the most contact with class I MHC, we expressed single-chain or dimeric forms of CD8 on COS-7 cells and measured the adhesion of MHC class I positive cells. We found that when one of the R4 residues was mutated in a CD8 alpha alpha homodimer binding comparable to that of wild type was observed, whereas a double R4 mutant severely impaired binding. However, when mutant CD8 alpha (R4K) was coexpressed with wild-type CD8 beta, binding was not observed. These results support the model in which it is CD8 alpha, not CD8 beta, that is making the most of the contact with MHC class I, including the alpha 2 domain. In addition, they demonstrate that a single-chain form of CD8 alpha alpha can bind to MHC class I.

Mesh:

Substances:

Year:  1999        PMID: 9916707

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Helicobacter pylori Deregulates T and B Cell Signaling to Trigger Immune Evasion.

Authors:  Victor E Reyes; Alex G Peniche
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

Review 2.  Molecular analysis of protein interactions mediating the function of the cell surface protein CD8.

Authors:  L Devine; P B Kavathas
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position.

Authors:  Rui Wang; Kannan Natarajan; David H Margulies
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

Review 4.  T cell receptor mimic antibodies for cancer therapy.

Authors:  Leonid Dubrovsky; Tao Dao; Ron S Gejman; Elliott J Brea; Aaron Y Chang; Claire Y Oh; Emily Casey; Dmitry Pankov; David A Scheinberg
Journal:  Oncoimmunology       Date:  2015-06-01       Impact factor: 8.110

5.  The crystal structure of CD8 in complex with YTS156.7.7 Fab and interaction with other CD8 antibodies define the binding mode of CD8 alphabeta to MHC class I.

Authors:  D A Shore; H Issafras; E Landais; L Teyton; I A Wilson
Journal:  J Mol Biol       Date:  2008-10-07       Impact factor: 5.469

6.  Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.

Authors:  Linda Wooldridge; Anna Lissina; Jonathan Vernazza; Emma Gostick; Bruno Laugel; Sarah L Hutchinson; Fareed Mirza; P Rod Dunbar; Jonathan M Boulter; Meir Glick; Vincenzo Cerundolo; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Eur J Immunol       Date:  2007-05       Impact factor: 5.532

7.  Relative Movements of Domains in Large Molecules of the Immune System.

Authors:  Wolfgang Schreiner; Rudolf Karch; Reiner Ribarics; Michael Cibena; Nevena Ilieva
Journal:  J Immunol Res       Date:  2015-12-21       Impact factor: 4.818

8.  Structure of MHC class I-like MILL2 reveals heparan-sulfate binding and interdomain flexibility.

Authors:  Mizuho Kajikawa; Toyoyuki Ose; Yuko Fukunaga; Yuki Okabe; Naoki Matsumoto; Kento Yonezawa; Nobutaka Shimizu; Simon Kollnberger; Masanori Kasahara; Katsumi Maenaka
Journal:  Nat Commun       Date:  2018-10-18       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.